![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 2796 |
FusionGeneSummary for ARNT_CRISPLD2 |
![]() |
Fusion gene information | Fusion gene name: ARNT_CRISPLD2 | Fusion gene ID: 2796 | Hgene | Tgene | Gene symbol | ARNT | CRISPLD2 | Gene ID | 375056 | 83716 |
Gene name | MIA SH3 domain ER export factor 3 | cysteine rich secretory protein LCCL domain containing 2 | |
Synonyms | ARNT|D320|TANGO|TANGO1|UNQ6077 | CRISP11|LCRISP2|LGL1 | |
Cytomap | 1q41 | 16q24.1 | |
Type of gene | protein-coding | protein-coding | |
Description | transport and Golgi organization protein 1 homologC219-reactive peptideMIA family member 3, ER export factormelanoma inhibitory activity family, member 3melanoma inhibitory activity protein 3transport and Golgi organization protein 1 | cysteine-rich secretory protein LCCL domain-containing 2CRISP-11LCCL domain-containing cysteine-rich secretory protein 2cysteine-rich secretory protein 11late gestation lung 1testis secretory sperm-binding protein Li 207atrypsin inhibitor | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P27540 | Q9H0B8 | |
Ensembl transtripts involved in fusion gene | ENST00000358595, ENST00000354396, ENST00000515192, ENST00000505755, ENST00000468970, | ENST00000262424, ENST00000567845, ENST00000566431, ENST00000564567, ENST00000569090, | |
Fusion gene scores | * DoF score | 6 X 6 X 3=108 | 2 X 2 X 2=8 |
# samples | 6 | 2 | |
** MAII score | log2(6/108*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: ARNT [Title/Abstract] AND CRISPLD2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ARNT | GO:0002687 | positive regulation of leukocyte migration | 17726152 |
Hgene | ARNT | GO:0007162 | negative regulation of cell adhesion | 17726152 |
Hgene | ARNT | GO:0030336 | negative regulation of cell migration | 17044017 |
Hgene | ARNT | GO:0042060 | wound healing | 17044017 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BM991829 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3UTR | ENST00000358595 | ENST00000262424 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000358595 | ENST00000567845 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000358595 | ENST00000566431 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000358595 | ENST00000564567 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000358595 | ENST00000569090 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-3UTR | ENST00000354396 | ENST00000262424 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000354396 | ENST00000567845 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000354396 | ENST00000566431 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000354396 | ENST00000564567 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000354396 | ENST00000569090 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-3UTR | ENST00000515192 | ENST00000262424 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000515192 | ENST00000567845 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000515192 | ENST00000566431 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000515192 | ENST00000564567 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000515192 | ENST00000569090 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-3UTR | ENST00000505755 | ENST00000262424 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000505755 | ENST00000567845 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000505755 | ENST00000566431 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000505755 | ENST00000564567 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000505755 | ENST00000569090 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-3UTR | ENST00000468970 | ENST00000262424 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000468970 | ENST00000567845 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000468970 | ENST00000566431 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000468970 | ENST00000564567 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
intron-intron | ENST00000468970 | ENST00000569090 | ARNT | chr1 | 150783004 | + | CRISPLD2 | chr16 | 84941953 | - |
Top |
FusionProtFeatures for ARNT_CRISPLD2 |
![]() |
Hgene | Tgene |
ARNT | CRISPLD2 |
Required for activity of the Ah (dioxin) receptor. Thisprotein is required for the ligand-binding subunit to translocatefrom the cytosol to the nucleus after ligand binding. The complexthen initiates transcription of genes involved in the activationof PAH procarcinogens. The heterodimer binds to core DNA sequence5'-TACGTG-3' within the hypoxia response element (HRE) of targetgene promoters and functions as a transcriptional regulator of theadaptive response to hypoxia (By similarity). The heterodimerARNT:AHR binds to core DNA sequence 5'-TGCGTG-3' within the dioxinresponse element (DRE) of target gene promoters and activatestheir transcription (PubMed:28396409).{ECO:0000250|UniProtKB:P53762, ECO:0000269|PubMed:28396409}. | Promotes matrix assembly. {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ARNT_CRISPLD2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ARNT_CRISPLD2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ARNT_CRISPLD2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ARNT_CRISPLD2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ARNT | C0000786 | Spontaneous abortion | 1 | CTD_human |
Hgene | ARNT | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Hgene | ARNT | C0014175 | Endometriosis | 1 | CTD_human |
Hgene | ARNT | C0023890 | Liver Cirrhosis | 1 | CTD_human |
Hgene | ARNT | C0025202 | melanoma | 1 | CTD_human |
Hgene | ARNT | C0027659 | Neoplasms, Experimental | 1 | CTD_human |
Hgene | ARNT | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1 | CTD_human |
Hgene | ARNT | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | CRISPLD2 | C0023895 | Liver diseases | 1 | CTD_human |
Tgene | CRISPLD2 | C0024115 | Lung diseases | 1 | CTD_human |
Tgene | CRISPLD2 | C0235032 | Neurotoxicity Syndromes | 1 | CTD_human |